| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Revenue | $6.1M | +175.2% |
| Cost of Revenue | $2.4M | +111.0% |
| Gross Profit | $3.7M | +241.5% |
| R&D Expense | $3.5M | +20.3% |
| SG&A Expense | $13.6M | +28.8% |
| Operating Income | -$13.9M | +0.3% |
| Interest Expense | $52K | -99.2% |
| Net Income | -$18.9M | +8.6% |
| EPS (Basic) | $0.00 |
| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.4M | +80.8% |
| Inventory | $1.6M | -25.7% |
| Current Assets | $5.0M | +39.0% |
| Total Assets | $11.0M | +44.6% |
| Current Liabilities | $7.6M | -65.1% |
| Total Liabilities | $60.5M | +26.6% |
| Stockholders' Equity | -$49.9M | -24.2% |
| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.2M | +5.8% |
| Capital Expenditures | $24K | +7.0% |
| Investing Cash Flow | -$80K | -2006.7% |
| Financing Cash Flow | $13.0M | +7.6% |
| Free Cash Flow | -$12.2M | +5.8% |
| — |
| EPS (Diluted) | $0.00 | — |